BDRX
Price
$1.45
Change
-$0.18 (-11.04%)
Updated
Feb 4 closing price
Capitalization
1.24M
Intraday BUY SELL Signals
VTGN
Price
$0.53
Change
-$0.01 (-1.85%)
Updated
Feb 4 closing price
Capitalization
20.78M
Intraday BUY SELL Signals
Interact to see
Advertisement

BDRX vs VTGN

Header iconBDRX vs VTGN Comparison
Open Charts BDRX vs VTGNBanner chart's image
Biodexa Pharmaceuticals
Price$1.45
Change-$0.18 (-11.04%)
Volume$3.81M
Capitalization1.24M
VistaGen Therapeutics
Price$0.53
Change-$0.01 (-1.85%)
Volume$849.43K
Capitalization20.78M
BDRX vs VTGN Comparison Chart in %
BDRX
Daily Signal:
Gain/Loss:
VTGN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BDRX vs. VTGN commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDRX is a Buy and VTGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (BDRX: $1.45 vs. VTGN: $0.53)
Brand notoriety: BDRX and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BDRX: 251% vs. VTGN: 25%
Market capitalization -- BDRX: $1.24M vs. VTGN: $20.78M
BDRX [@Biotechnology] is valued at $1.24M. VTGN’s [@Biotechnology] market capitalization is $20.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDRX’s FA Score shows that 1 FA rating(s) are green whileVTGN’s FA Score has 1 green FA rating(s).

  • BDRX’s FA Score: 1 green, 4 red.
  • VTGN’s FA Score: 1 green, 4 red.
According to our system of comparison, both BDRX and VTGN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDRX’s TA Score shows that 5 TA indicator(s) are bullish while VTGN’s TA Score has 4 bullish TA indicator(s).

  • BDRX’s TA Score: 5 bullish, 2 bearish.
  • VTGN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BDRX is a better buy in the short-term than VTGN.

Price Growth

BDRX (@Biotechnology) experienced а -30.29% price change this week, while VTGN (@Biotechnology) price change was -10.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.41%. For the same industry, the average monthly price growth was +1.41%, and the average quarterly price growth was +32.47%.

Industries' Descriptions

@Biotechnology (-2.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTGN($20.8M) has a higher market cap than BDRX($1.24M). VTGN YTD gains are higher at: -20.502 vs. BDRX (-36.123). BDRX has higher annual earnings (EBITDA): -5.56M vs. VTGN (-64.79M). VTGN has higher revenues than BDRX: VTGN (721K) vs BDRX (0).
BDRXVTGNBDRX / VTGN
Capitalization1.24M20.8M6%
EBITDA-5.56M-64.79M9%
Gain YTD-36.123-20.502176%
P/E RatioN/AN/A-
Revenue0721K-
Total CashN/A77.2M-
Total DebtN/A1.87M-
FUNDAMENTALS RATINGS
BDRX vs VTGN: Fundamental Ratings
BDRX
VTGN
OUTLOOK RATING
1..100
7081
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
15
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
9797
P/E GROWTH RATING
1..100
94100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTGN's Valuation (15) in the Biotechnology industry is in the same range as BDRX (26). This means that VTGN’s stock grew similarly to BDRX’s over the last 12 months.

VTGN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as BDRX (100). This means that VTGN’s stock grew similarly to BDRX’s over the last 12 months.

VTGN's SMR Rating (98) in the Biotechnology industry is in the same range as BDRX (99). This means that VTGN’s stock grew similarly to BDRX’s over the last 12 months.

VTGN's Price Growth Rating (97) in the Biotechnology industry is in the same range as BDRX (97). This means that VTGN’s stock grew similarly to BDRX’s over the last 12 months.

BDRX's P/E Growth Rating (94) in the Biotechnology industry is in the same range as VTGN (100). This means that BDRX’s stock grew similarly to VTGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BDRXVTGN
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 21 days ago
75%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
78%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
BDRX
Daily Signal:
Gain/Loss:
VTGN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLMT24.510.52
+2.17%
Calumet Inc.
RIBB10.47N/A
N/A
Ribbon Acquisition Corp
PSKY10.75-0.06
-0.56%
Paramount Skydance Corporation
WNC11.04-0.20
-1.78%
Wabash National Corp
STRK78.95-2.30
-2.83%
MicroStrategy Inc

BDRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDRX has been closely correlated with QNCX. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if BDRX jumps, then QNCX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDRX
1D Price
Change %
BDRX100%
-11.04%
QNCX - BDRX
79%
Closely correlated
+9.28%
MREO - BDRX
75%
Closely correlated
-2.73%
RZLT - BDRX
73%
Closely correlated
-7.62%
TPST - BDRX
72%
Closely correlated
-1.24%
BCAB - BDRX
71%
Closely correlated
+11.06%
More

VTGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been closely correlated with QNCX. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if VTGN jumps, then QNCX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
-3.20%
QNCX - VTGN
92%
Closely correlated
+9.28%
RZLT - VTGN
87%
Closely correlated
-7.62%
GNTA - VTGN
83%
Closely correlated
-1.27%
IMRN - VTGN
79%
Closely correlated
-3.43%
BDRX - VTGN
79%
Closely correlated
-11.04%
More